Form 4: Bruker Corp Director John Ornell Exercises Stock Options
SEC Form 4 Filing
Director John Ornell exercised stock options to acquire 5,000 shares of Bruker Corp common stock at $18.15 per share.
Summary
- On May 13, 2025, John Ornell, a director of Bruker Corporation, exercised stock options.
- This transaction involved the acquisition of 5,000 shares of common stock at a price of $18.15 per share.
- Following the transaction, Ornell directly owns 31,445 shares of Bruker Corp.
- The stock options were originally granted on August 25, 2015, and vested in equal installments over three years.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity.
Positives
- The director's exercise of stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares relative to the company's total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 2015-08-25 | Original Grant Date of the stock options |
| 2025-02-24 | Date of Power of Attorney execution |
| 2025-05-13 | Date of stock option exercise |
| 2025-05-14 | Date of signature for the Form 4 filing |
| 2025-08-25 | Expiration date of the stock options |
Keywords
Form 4, Bruker Corp, Director, Stock Options, BRKR, John Ornell, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.